// App-Quantinova.ai

LB-274 : A prospective multicenter study

Researchers

Presenter

  • Manik Garg

Principal Investigators

  • Dominique-Laurent Courturier

  • Nuno A. Fonseca

  • Matthew Wongchenko

  • Yibing Yan

  • Jeremie Nsengimana

  • Tim Bishop

  • Julia Newton-Bishop

  • Mark Middleton

  • Pippa Corrie

  • David J. Adams

  • Alvis Brazma

  • Roy Rabbie

Medical Centers

  • European Molecular Biology Laboratory - European Bioinformatics Institute, Hinxton, United Kingdom

  • Cancer Research UK Cambridge Institute, University of Cambridge., Cambridge, United Kingdom

  • CIBIO/InBIO-Centro de Investigação em Biodiversidade e Recursos Genéticos, Universidade do Porto, Rua Padre Armando Quintas, Vairão, Portugal

  • Oncology Biomarker Development, Genentech Inc., South San Francisco, CA

  • University of Leeds, School of Chemistry, Leeds, United Kingdom

  • Oxford NIHR Biomedical Research Centre, Oxford, United Kingdom

  • Cambridge Cancer Trials Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

  • Experimental Cancer Genetics, The Wellcome Sanger Institute, Hinxton, United Kingdom

Locations

  • United Kingdom

  • Portugal

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Randomized

  • Multicenteric

  • Prospective

  • Controlled

  • Cohort

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A